FDA Inspection 898074 — Regenerative Biologics, Inc.

Regenerative Biologics, Inc. — FEI 3009510408

The FDA completed an inspection of Regenerative Biologics, Inc. on Sep 30, 2014 in Tampa, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Sep 30, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Tampa, FL (United States)